Normal variants in [18F]-fluorodeoxyglucose PET imaging

被引：29

作者：

El-Haddad, G ^{[1
]}

Alavi, A ^{[1
]}

Mavi, A ^{[1
]}

Bural, G ^{[1
]}

Zhuang, HM ^{[1
]}

机构：

[1] Hosp Univ Penn, Dept Radiol, Div Nucl Med, Philadelphia, PA 19104 USA

来源：

RADIOLOGIC CLINICS OF NORTH AMERICA | 2004年 / 42卷 / 06期

关键词：

D O I：

10.1016/j.rcl.2004.07.003

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 [临床医学]; 100207 [影像医学与核医学]; 1009 [特种医学];

摘要：

The number of fluorodeoxyglucose PET applications is increasing. In the process of reading fluorodeoxyglucose-PET scans, nuclear medicine physicians encounter a wide variety of normal findings, which must be recognized to determine the best management for patients. It is important to recognize and understand normal variants to avoid misinterpretation of more serious pathology. This article reviews different patterns of physiologic fluorodeoxyglucose uptake including changes with age.

引用

页码：1063 / +

页数：20

共 74 条

[1]

Positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose in oncology Part II.: The clinical value in detecting and staging primary tumours [J].

Ak, I ;

Stokkel, MPM ;

Pauwels, EKJ .

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2000, 126 (10) :560-574

[2]

Implications of PET based molecular imaging on the current and future practice of medicine [J].

Alavi, A ;

Kung, JW ;

Zhuang, HM .

SEMINARS IN NUCLEAR MEDICINE, 2004, 34 (01) :56-69

[3]

Positron emission tomography imaging in nonmalignant thoracic disorders [J].

Alavi, A ;

Gupta, N ;

Alberini, JL ;

Hickeson, M ;

Adam, LE ;

Bhargava, P ;

Zhuang, HM .

SEMINARS IN NUCLEAR MEDICINE, 2002, 32 (04) :293-321

[4]

Normal thymic uptake of 2-deoxy-2[F-18]fluoro-D-glucose [J].

Alibazoglu, H ;

Alibazoglu, B ;

Hollinger, EF ;

Ingram, SA ;

Willoughby, WA ;

LaMonica, G ;

Ali, A .

CLINICAL NUCLEAR MEDICINE, 1999, 24 (08) :597-600

[5]

Avril N, 2001, J NUCL MED, V42, P9

[6]

Positron emission tomography with 18-F-fluorodeoxyglucose in the staging and follow-up of lymphoma: Status quo and quo vadis [J].

Bangerter, M ;

Griesshammer, M ;

Kotzerke, J ;

Reske, SN ;

Bergmann, L .

ONKOLOGIE, 1999, 22 (05) :382-386

[7]

Limitations of PET for imaging lymphoma [J].

Barrington, Sally F. ;

O'Doherty, Michael J. .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2003, 30 (Suppl 1) :S117-S127

[8]

Barrington SF, 1996, J NUCL MED, V37, P1127

[9]

Biologic correlates of 18fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography [J].

Bos, R ;

van der Hoeven, JJM ;

van der Wall, E ;

van der Groep, P ;

van Diest, PJ ;

Comans, EFI ;

Joshi, U ;

Semenza, GL ;

Hoekstra, OS ;

Lammertsma, AA ;

Molthoff, CFM .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (02) :379-387

[10]

Brink I, 2001, J NUCL MED, V42, P591

← 1 2 3 4 5 6 7 8 →